Medipal Holdings signs contract to set up JV JCR USA with JCR Pharmaceuticals
Dec 19(Reuters) - Medipal Holdings Corp <7459.T>:Says it signed a contract to set up a JV JCR USA Inc with JCR Pharmaceuticals Co Ltd <<<4552.T>>>.Says the JV will be established in January 2018.Says the company and JCR Pharmaceuticals will hold a 35 percent stake and a 65 percent stake in the JV respectively .
Latest Developments forJCR Pharmaceuticals Co Ltd
- JCR Pharmaceuticals initiates phase 3 clinical trial of JR-141 for Hunter Syndrome
- JCR Pharmaceuticals initiates phase 2 clinical trial of JR-141 for hunter syndrome in Brazil
- JCR Pharmaceuticals to recall partial sleep apnea alarm products
- JR-131, long-acting erythropoiesis-stimulating agent, demonstrates equivalence in phase III study
Latest Key Developments inPharmaceuticals
- Delta 9 Cannabis Reports Q4 Loss Per Share Of $0.02
- Enzo Biochem Says Co's Unit Enters Into Settlement, License Agreement With Hologic, Grifols S.A
- Teva Announces Launch Of A Generic Version Of Vesicare Tablets In U.S.
- Zhejiang Hisun Pharmaceutical Swings To Red In 2018 With Net Loss Of 492.5 Mln Yuan